Fluticasone and Salmeterol Oral Inhalati... Clinical Trials

• The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial (The LOCCS Trial)
  ClinicalTrials.gov Identifier: NCT00156819 - Active, not recruiting
  Asthma
  
• Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD
  ClinicalTrials.gov Identifier: NCT00530842 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
  ClinicalTrials.gov Identifier: NCT00364442 - Completed
  Asthma
  
• A Pilot Study of the Mechanism of Synergism between Fluticasone (FP) and Salmeterol in Preventing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
  ClinicalTrials.gov Identifier: NCT00116402 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma
  ClinicalTrials.gov Identifier: NCT00441441 - Active, not recruiting
  Asthma
  
• Study of Asthma in Patients of African Descent
  ClinicalTrials.gov Identifier: NCT00102765 - Active, not recruiting
  Asthma
  
• A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD
  ClinicalTrials.gov Identifier: NCT00239421 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Advair DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS (Salmeterol) for Chronic Obstructive Pulmonary Disease Exacerbations
  ClinicalTrials.gov Identifier: NCT00115492 - Completed
  Chronic Obstructive Pulmonary Disease
  
• A Study Measuring Asthma Control in Pediatric and Adolescent Subjects Whose Asthma is Worsened by Activity Or Exercise
  ClinicalTrials.gov Identifier: NCT00118690 - Active, not recruiting
  Bronchospasm; Asthma, Exercise-Induced
  
• Asthma Control in Pediatric and Adolescent Subjects Whose Asthma is Worsened by Activity Or Exercise
  ClinicalTrials.gov Identifier: NCT00118716 - Active, not recruiting
  Bronchospasm; Asthma, Exercise-Induced
  
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00452348 - Recruiting
  Asthma
  
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
  ClinicalTrials.gov Identifier: NCT00452699 - Recruiting
  Asthma
  
• Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
  ClinicalTrials.gov Identifier: NCT00480649 - Active, not recruiting
  Asthma
  
• Advair® DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS® (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations
  ClinicalTrials.gov Identifier: NCT00144911 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139)
  ClinicalTrials.gov Identifier: NCT00379288 - Active, not recruiting
  Asthma
  
• Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects
  ClinicalTrials.gov Identifier: NCT00517634 - Not yet recruiting
  Asthma
  
• A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
  ClinicalTrials.gov Identifier: NCT00274534 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
  ClinicalTrials.gov Identifier: NCT00497237 - Recruiting
  Asthma
  
• The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
  ClinicalTrials.gov Identifier: NCT00559312 - Not yet recruiting
  COPD
  
• Study Of Asthma And Genetics
  ClinicalTrials.gov Identifier: NCT00102882 - Completed
  Asthma
  
• Influence Of Salmeterol/Fluticasone (50/500BD)On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV
  ClinicalTrials.gov Identifier: NCT00527826 - Not yet recruiting
  COPD
  
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
  ClinicalTrials.gov Identifier: NCT00435461 - Active, not recruiting
  Hayfever; Allergic Rhinitis
  
• NO Donors and Inhibitors Study
  ClinicalTrials.gov Identifier: NCT00159380 - Recruiting
  Asthma; Healthy volunteers
  
• Comparator Study Evaluating Patient Preference Of Fluticasone Furoate Nasal Spray vs. Fluticasone Propionate Nasal Spray
  ClinicalTrials.gov Identifier: NCT00539006 - Active, not recruiting
  Seasonal Allergic Rhinitis
  
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
  ClinicalTrials.gov Identifier: NCT00502775 - Recruiting
  Allergic Rhinitis; Hay Fever
  
• Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00388882 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in COPD
  ClinicalTrials.gov Identifier: NCT00239499 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Airway Hyper-Responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product
  ClinicalTrials.gov Identifier: NCT00291382 - Completed
  Asthma
  
• EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
  ClinicalTrials.gov Identifier: NCT00394368 - Completed
  Bronchial Asthma
  
• Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)
  ClinicalTrials.gov Identifier: NCT00163358 - Completed
  Asthma
  
• A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00359788 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Pediatric Asthma Study Using Stepwise Treatment With Two FDA Approved Asthma Medications
  ClinicalTrials.gov Identifier: NCT00158834 - Completed
  Children aged 6-16 year, with moderate/ severe asthma using inhaled steroids.
  
• Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
  ClinicalTrials.gov Identifier: NCT00123656 - Recruiting
  Esophagitis
  
• ADVAIR DISKUS (Fluticasone Propionate/Salmeterol) Versus SEREVENT DISKUS (Salmeterol) On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00346749 - Terminated
  Chronic Obstructive Pulmonary Disease
  
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00332488 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
  ClinicalTrials.gov Identifier: NCT00116311 - Active, not recruiting
  Asthma; Healthy
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• The Effect of Salmeterol on Eosinophil Function
  ClinicalTrials.gov Identifier: NCT00214019 - Active, not recruiting
  Mild Allergic Asthma
  
• Safety Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. Aeruginosa
  ClinicalTrials.gov Identifier: NCT00128492 - Active, not recruiting
  Cystic Fibrosis
  
• Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)
  ClinicalTrials.gov Identifier: NCT00163488 - Completed
  Perennial Allergic Rhinitis; Allergic Rhinitis; Hay Fever
  
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00388505 - Recruiting
  Cystic Fibrosis
  
• Fluticasone Nasal Spray Patient Preference Study
  ClinicalTrials.gov Identifier: NCT00398476 - Active, not recruiting
  Allergic Rhinitis
  
• The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
  ClinicalTrials.gov Identifier: NCT00060840 - Recruiting
  Congestive Heart Failure
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma
  ClinicalTrials.gov Identifier: NCT00238927 - Active, not recruiting
  Asthma
  
• Modification Of Disease Outcome In COPD
  ClinicalTrials.gov Identifier: NCT00158847 - Terminated
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00394199 - Active, not recruiting
  Asthma
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Wild Type p53 Adenovirus for Oral Premalignancies
  ClinicalTrials.gov Identifier: NCT00410865 - Active, not recruiting
  Mouth Cancer; Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity; Dysplasia/Carcinoma in Situ (CIS) of the Oral Pharynx
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD
  ClinicalTrials.gov Identifier: NCT00535366 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
  ClinicalTrials.gov Identifier: NCT00154973 - Recruiting
  Oral Cancer
  
• Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
  ClinicalTrials.gov Identifier: NCT00250289 - Recruiting
  Halitosis; Oral Malodor; Bad Breath
  
• A study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial
  ClinicalTrials.gov Identifier: NCT00081653 - Active, not recruiting
  Osteoporosis
  
• A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00323518 - Active, not recruiting
  Oral Mucositis; Stomatitis
  
• Staccato® Prochlorperazine for Inhalation in Migraine
  ClinicalTrials.gov Identifier: NCT00422812 - Active, not recruiting
  Migraine Headache; Aura
  
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Sallmeterol Inhalation Aerosol.
  ClinicalTrials.gov Identifier: NCT00274560 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00232648 - Active, not recruiting
  Asthma
  
• Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00422604 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
  ClinicalTrials.gov Identifier: NCT00570492 - Recruiting
  Perennial Allergic Rhinitis
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
  ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
  Asthma
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
  ClinicalTrials.gov Identifier: NCT00560625 - Recruiting
  Adrenal Insufficency
  
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00357279 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
  ClinicalTrials.gov Identifier: NCT00475371 - Active, not recruiting
  Diabetes Mellitus, Type 2; Healthy Males
  
• Study of Dust Mite Inhalation in Humans
  ClinicalTrials.gov Identifier: NCT00448851 - Recruiting
  Mild Asthma; Allergy
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
  ClinicalTrials.gov Identifier: NCT00350207 - Recruiting
  Asthma
  
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00393991 - Recruiting
  Asthma
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• A Peri-Intubation Oral Intervention to Reduce Oral Flora and VAP
  ClinicalTrials.gov Identifier: NCT00248300 - Recruiting
  Pneumonia
  
• Effects of Oral Care in the Neuroscience ICU
  ClinicalTrials.gov Identifier: NCT00518752 - Recruiting
  Ventilator Associated Pneumonia; Oral Hygiene
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Oral Budesonide vs. Oral Mesalazine in Active CD
  ClinicalTrials.gov Identifier: NCT00300118 - Recruiting
  Crohn's Disease
  
• Efficacy and Safety Study for an Oral Contraceptive Containing Folate
  ClinicalTrials.gov Identifier: NCT00468481 - Recruiting
  Oral Contraception
  
• Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
  ClinicalTrials.gov Identifier: NCT00000111 - Active, not recruiting
  Mouth Diseases
  
• A Randomized Study of Sulindac in Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00299195 - Recruiting
  Leukoplakia, Oral; Benign Neoplasms
  
• Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00507182 - Recruiting
  Oral Cancer
  
• Responsiveness of Lower Airways in Adult Patients (18-60 y) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
  ClinicalTrials.gov Identifier: NCT00306163 - Recruiting
  Asthma
  
• Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00502580 - Recruiting
  Oral Cancer
  
• In Vivo Confocal Imaging of Oral Mucosa
  ClinicalTrials.gov Identifier: NCT00502125 - Recruiting
  Oral Tumors
  
• Efficacy of Elidel Cream on Erosive Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00130572 - Recruiting
  Lichen Planus, Oral
  
• Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00355290 - Recruiting
  Blood Coagulation Disorders
  
• Fenretinide in Treating Patients With Leukoplakia of the Mouth
  ClinicalTrials.gov Identifier: NCT00004161 - Active, not recruiting
  prevention of oral cancer
  
• Elective vs Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00193765 - Recruiting
  Oral Cancer
  
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00323219 - Recruiting
  Cellulitis
  
• Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
  ClinicalTrials.gov Identifier: NCT00484822 - Recruiting
  Long-Term Oral Anticoagulant Therapy
  
• Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics
  ClinicalTrials.gov Identifier: NCT00527462 - Recruiting
  Asthma